These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 15727863

  • 1. New naphthylcombretastatins. Modifications on the ethylene bridge.
    Sánchez Maya AB, Pérez-Melero C, Salvador N, Peláez R, Caballero E, Medarde M.
    Bioorg Med Chem; 2005 Mar 15; 13(6):2097-107. PubMed ID: 15727863
    [Abstract] [Full Text] [Related]

  • 2. Naphthalene combretastatin analogues: synthesis, cytotoxicity and antitubulin activity.
    Medarde M, Maya AB, Pérez-Melero C.
    J Enzyme Inhib Med Chem; 2004 Dec 15; 19(6):521-40. PubMed ID: 15662956
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety.
    Maya AB, Pérez-Melero C, Mateo C, Alonso D, Fernández JL, Gajate C, Mollinedo F, Peláez R, Caballero E, Medarde M.
    J Med Chem; 2005 Jan 27; 48(2):556-68. PubMed ID: 15658869
    [Abstract] [Full Text] [Related]

  • 6. Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4.
    Hall JJ, Sriram M, Strecker TE, Tidmore JK, Jelinek CJ, Kumar GD, Hadimani MB, Pettit GR, Chaplin DJ, Trawick ML, Pinney KG.
    Bioorg Med Chem Lett; 2008 Sep 15; 18(18):5146-9. PubMed ID: 18710804
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis and cytotoxic evaluation of combretafurans, potential scaffolds for dual-action antitumoral agents.
    Pirali T, Busacca S, Beltrami L, Imovilli D, Pagliai F, Miglio G, Massarotti A, Verotta L, Tron GC, Sorba G, Genazzani AA.
    J Med Chem; 2006 Aug 24; 49(17):5372-6. PubMed ID: 16913727
    [Abstract] [Full Text] [Related]

  • 9. Combretastatin dinitrogen-substituted stilbene analogues as tubulin-binding and vascular-disrupting agents.
    Siles R, Ackley JF, Hadimani MB, Hall JJ, Mugabe BE, Guddneppanavar R, Monk KA, Chapuis JC, Pettit GR, Chaplin DJ, Edvardsen K, Trawick ML, Garner CM, Pinney KG.
    J Nat Prod; 2008 Mar 24; 71(3):313-20. PubMed ID: 18303849
    [Abstract] [Full Text] [Related]

  • 10. Design, synthesis, and biological evaluation of combretastatin nitrogen-containing derivatives as inhibitors of tubulin assembly and vascular disrupting agents.
    Monk KA, Siles R, Hadimani MB, Mugabe BE, Ackley JF, Studerus SW, Edvardsen K, Trawick ML, Garner CM, Rhodes MR, Pettit GR, Pinney KG.
    Bioorg Med Chem; 2006 May 01; 14(9):3231-44. PubMed ID: 16442292
    [Abstract] [Full Text] [Related]

  • 11. Structural requirements for the interaction of combretastatins with tubulin: how important is the trimethoxy unit?
    Gaukroger K, Hadfield JA, Lawrence NJ, Nolan S, McGown AT.
    Org Biomol Chem; 2003 Sep 07; 1(17):3033-7. PubMed ID: 14518125
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and biological activity of fluorinated combretastatin analogues.
    Alloatti D, Giannini G, Cabri W, Lustrati I, Marzi M, Ciacci A, Gallo G, Tinti MO, Marcellini M, Riccioni T, Guglielmi MB, Carminati P, Pisano C.
    J Med Chem; 2008 May 08; 51(9):2708-21. PubMed ID: 18396857
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Design, synthesis and biological evaluation of dihydronaphthalene and benzosuberene analogs of the combretastatins as inhibitors of tubulin polymerization in cancer chemotherapy.
    Sriram M, Hall JJ, Grohmann NC, Strecker TE, Wootton T, Franken A, Trawick ML, Pinney KG.
    Bioorg Med Chem; 2008 Sep 01; 16(17):8161-71. PubMed ID: 18722127
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A new family of quinoline and quinoxaline analogues of combretastatins.
    Pérez-Melero C, Maya AB, del Rey B, Peláez R, Caballero E, Medarde M.
    Bioorg Med Chem Lett; 2004 Jul 16; 14(14):3771-4. PubMed ID: 15203159
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. p,p-Dihydroxydihydrostilbenophanes related to antimitotic combretastatins. Conformational analysis and its relationship to tubulin inhibition.
    Álvarez R, López V, Mateo C, Medarde M, Peláez R.
    J Org Chem; 2014 Aug 01; 79(15):6840-57. PubMed ID: 24966024
    [Abstract] [Full Text] [Related]

  • 19. Development of combretastatins as potent tubulin polymerization inhibitors.
    Bukhari SNA, Kumar GB, Revankar HM, Qin HL.
    Bioorg Chem; 2017 Jun 01; 72():130-147. PubMed ID: 28460355
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis and cytotoxic activities of naphthyl analogues of combretastatin A-4.
    Maya AB, del Rey B, Lamamie de Clairac RP, Caballero E, Barasoain I, Andreu JM, Medarde M.
    Bioorg Med Chem Lett; 2000 Nov 20; 10(22):2549-51. PubMed ID: 11086727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.